Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiation

Autor: Nathalie Forgeard, Marine Baron, Jonathan Caron, Clementine Boccon-Gibod, Daphne Krzisch, Nayara Guedes, Veronique Morel, Nathalie Jacque, Maya Ouzegdouh, Sylvain Choquet, Clotilde Bravetti, Florence Nguyen-Khac, Elise Chapiro, Veronique Leblond, Damien Roos-Weil

Publikováno v: Haematologica, Vol 107, Iss 11 (2022)

Externí odkaz: https://doaj.org/article/8e39d02f05074da4ab905ed5259c5b64

A transition from using multi‐step procedures to a fully integrated system for performing extracorporeal photopheresis: A comparison of costs and efficiencies

Autor: Paul Button, Véronique Leblond, Maya Ouzegdouh, Nabih Azar

Publikováno v: Journal of Clinical Apheresis

Introduction The Pitie Salpetriere Hospital Hemobiotherapy Department, Paris, France, has been providing extracorporeal photopheresis (ECP) since November 2011, and started using the Therakos® CELLEX® fully integrated system in 2012. This report su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45fef315055e9179cb9793f5a00bea62
http://europepmc.org/articles/PMC5724655

The Role of PET-MRI in Multiple Myeloma Patients

Autor: Véronique Morel, Damien roos Weil, Nathalie Jacque, Adrien Grenier, Aurélie Kas, Suella Martino, Olivier Lucidarme, Choquet Sylvain, Maya Ouzegdouh Ouarab, Laurent Garderet, Driss Kharroubi-Lakouas, Veronique Leblond

Publikováno v: Blood. 136:12-12

Introduction Low-dose CT scans and magnetic resonance imaging (MRI) using T2- and T1-weighted contrasted enhanced images are the standard methods of bone staging for newly diagnosed and relapsed multiple myeloma (MM) patients. Fluoro-desoxy-glucose p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e8cc761486bb24d3d252c8a8da92345d
https://doi.org/10.1182/blood-2020-141789

A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone

Autor: Julie Lejeune, Carole Soussain, Xavier Leleu, Brigitte Dreyfus, Caroline Dartigeas, Véronique Leblond, Stéphane Leprête, Sylvie Chevret, Marie-Sarah Dilhuidy, Anne Banos, Thérèse Aurran, Brigitte Pegourie, Olivier Tournilhac, Herve Oya, Beatrice Mahe, Bruno Anglaret, Caroline Besson, Anne Vekhoff, Pierre Morel, Maya Ouzegdouh

Publikováno v: Leukemia & lymphoma
Leukemia & lymphoma, Taylor & Francis, 2017, 58 (11), pp.2615-2623. ⟨10.1080/10428194.2017.1307357⟩
Leukemia & lymphoma, Taylor & Francis, 2017, 58 (11), pp.2615-2623. 〈10.1080/10428194.2017.1307357〉
Leukemia & lymphoma, 2017, 58 (11), pp.2615-2623. ⟨10.1080/10428194.2017.1307357⟩

In patients with advanced Waldenström macroglobulinemia (WM), overall response rate (ORR) and median progression-free survival (PFS) achieved with bortezomib alone and bortezomib rituximab combination were 27-85% and 7.9 months, and 81% and 16.4 mon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f17c36bc619884109a0b417760710e1
https://hal.archives-ouvertes.fr/hal-01655961

Impact of plerixafor (mozobil) on hospital efficiency: A single center experience

Autor: Nabih Azar, Sylvain Choquet, Véronique Leblond, Maya Ouzegdouh

Publikováno v: Journal of clinical apheresis. 33(1)

Plerixafor (Mozobil) in combination with granulocyte colony-stimulating factor (G-CSF) has shown to increase mobilization of peripheral blood stem cells (PBSC) as compared to G-CSF alone in patients undergoing autologous stem cell transplantation (AS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c159ed2655b270c36ae791215b032643
https://pubmed.ncbi.nlm.nih.gov/28455878